Related Episodes for Differences in tissue-specific utilization of NAD+ boosters (NAD+ flux study) | Rhonda Patrick

“In contrast, a five-week trial in 181 people with diabetic polyneuropathy found that oral alpha-lipoic acid improved symptom scores, with more nausea, vomiting, and vertigo at higher doses. PQQ has a much smaller human evidence base.”